Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Comment by c4063svon May 18, 2021 1:08pm
157 Views
Post# 33222646

RE:Q1 Financials available on Sedar

RE:Q1 Financials available on Sedar
Medivolve Inc. (formerly QuestCap Inc.)
Condensed Interim Consolidated Statements of Financial Position 
Unaudited
(Expressed in Canadian dollars)
ASSETS
Current assets
Cash $ 477,936 $ 851,409 
Inventory 483,838 232,786 
Public investments at fair value through profit and loss 6 607,926 403,563 
Amounts receivable 4,16 3,343,025 2,312,728 
Note and loans receivable 3 557,337 548,605 
Prepaid expenses and advances 5 935,765 330,682 
Total current assets 6,405,827 4,679,773 
Private investments at fair value through profit and loss 6 1,765,788 3,162,369 
Royalty interest 7 500,000 500,000 
Property and equipment 8 638,302 668,778 
Right-of-use assets 1 2 716,359 7,877,826 
Intangibles 1 0 7,096,854 2,242,500 
TOTAL ASSETS $ 17,123,130 $ 19,131,246 
LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIENCY)
Current liabilities
Accounts payable and accrued liabilities 6, 16 $ 10,404,221 $ 6,674,882
Loans payable 11,16 8,717,180 13,434,363
Lease liabilities 1 2 715,850 6,775,229
Other liabilities 7 105,835 2,260,774
Total liabilities $ 19,943,086 $ 29,145,248
Shareholders' Equity
Share capital 1 3 $ 56,737,308 $ 41,269,852
Share-based payment reserve 1 4 5,386,106 3,699,378
Accumulated other comprehensive income 128,687 105,580
Deficit (65,072,057) (55,088,812)
Total shareholders' equity (deficiency) $ (2,819,956) $ (10,014,002)
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIENCY) $ 17,123,130 $ 19,131,246
<< Previous
Bullboard Posts
Next >>